Medifast, Inc. reported earnings results for the third quarter and nine months ended September 30, 2026. For the third quarter, the company reported sales was USD 72.05 million compared to USD 89.41 ...
Medifast (NYSE:MED) reported third-quarter 2026 revenue of $72 million, down 19.4% from a year earlier, as the company continued to face a sharp decline in its active earning coach base. Management sa ...
Medifast, Inc. provided earnings guidance for the fourth quarter and full year of 2026. For the quarter, the company expects fourth quarter 2026 revenue to be in the range of $55 million to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results